Genenta Science Past Earnings Performance

Past criteria checks 0/6

Genenta Science's earnings have been declining at an average annual rate of -21.9%, while the Biotechs industry saw earnings growing at 7.7% annually.

Key information

-21.9%

Earnings growth rate

-17.9%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth raten/a
Return on equity-53.1%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Genenta Science makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:K5F Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-955
31 Mar 240-1056
31 Dec 230-1256
30 Sep 230-1267
30 Jun 230-1368
31 Mar 230-1166
31 Dec 220-865
30 Sep 220-654
30 Jun 220-442
31 Mar 220-533
31 Dec 210-623
30 Sep 210-625
30 Jun 210-716
31 Mar 210-615
31 Dec 200-615

Quality Earnings: K5F is currently unprofitable.

Growing Profit Margin: K5F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: K5F is unprofitable, and losses have increased over the past 5 years at a rate of 21.9% per year.

Accelerating Growth: Unable to compare K5F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: K5F is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.8%).


Return on Equity

High ROE: K5F has a negative Return on Equity (-53.07%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies